// App-Quantinova.ai

: Spare the Spleen in ALPS: It Is Not an Expendable Vestigial Organ

Researchers

Presenter

  • V. Koneti Rao

Principal Investigators

  • Elaine Kulm

  • Susan Price

  • Sharon Webster

  • Les Folio

  • Gulbu Uzel

  • David T Teachey

Medical Centers

  • National Institute of Health, Bethesda, MD

  • Room 10/12C106, NIAID National Institutes of Health, Bethesda, MD

  • National Institute of Health, Bethesda, MD

  • NIH Clinical Center, Bethesda, MD

  • Center for Childhood Cancer Research, Childrens Hospital of Philadelphia, Philadelphia, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Infectious Diseases (ID)

  • Oncology (ONC)

  • Cardiovascular (CVS)

  • Genetic Disorder

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Hypogammaglobulinaemia

  • Deep vein thrombosis

  • Venous thrombosis

  • Lymphomas

  • Sepsis

  • Autoimmune lymphoproliferative syndromes

Biomarkers

  • DNA Damage Inducible Transcript 3

Drug/Treatment

  • Mycophenolate mofetil

  • CKD-4101

  • Rapacan

  • Rituximab

Outcome

  • N/A

Study Design

  • Multicenteric

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved